• Cell Therapy Scale-Up Strategies For Commercial Success

    To achieve commercial success, a developed process must be scalable and suitable for a manufacturing environment. The scaling strategy depends on the type of cell therapy. This article discusses options for cell therapy process development and validation that minimize risks through quality control (QC), optimization, scaling, closing, automation, and assay development, all in order to prepare for successful commercial production.

  • Precision Powder In Capsule Micro Dosing Accelerates Drug Product Development

    Advancing active pharmaceutical ingredients (APIs) through the drug product-development lifecycle is fraught with challenges. Development timelines are tight, so it’s crucial to determine early in the process if an API is a viable candidate for clinical testing. A key tool that has emerged to address these combined issues of tight timelines and complex molecules is precision powder micro-dosing in capsules. This paper describes the use of precision micro-dosing to prepare API powder-in-capsule (PIC) dosage forms for oral or pulmonary administration.

  • Particle Engineering For Respiratory Drug Delivery

    The increase in pulmonary illnesses has added to the need for drug products that are safe and efficacious. A key to efficacy is the control of the mass median aerodynamic diameter (MMAD) particle size via particle engineering. This paper explains Lonza’s inhalation and particle engineering platforms.

  • Opportunities In Preclinical Development

    Finding ways to optimize the holistic preclinical development.

  • A Small-Scale Model To Increase Yield In Cell Culture Perfusion Of mAb At Large Scale

    As process intensification is adopted into large scale manufacturing, the responsibility on scale-down models to accurately represent the expanded operating space quickly follows. Perfusion continues to be one such operating mode which lends itself to adding benefit at the manufacturing scale while adding complexity to the small-scale approach. The purpose of the described study was to develop a reliable small-scale model of our perfusion process in the ReadyToProcess WAVE 25 Rocker bioreactor and WAVE Cellbag 50 L.

  • Using In-Line Sensors For Real-Time Control

    Within biopharmaceutical production there is a shift from manually monitoring processes to real-time control and automated intervention. The goal is to develop algorithms and AI solutions which are able predict outcomes and create autonomous systems. The first step towards this goal is to use reliable and robust in-line sensors for real-time process control. This paper exemplifies how to use available and reliable sensors for in-process control of several different upstream and downstream process parameters.

  • Developing A Closed Connected Single Use mAb Purification Process

    Pharmaceutical manufacturers are striving for more diversified portfolios targeting a greater number of monoclonal antibodies (mAb), the key to driving down overall costs is to lower capital expenditure (CAPEX) investments by better utilization of equipment. This article provides an overview of a successfully designed a closed and physically connected mAb process at the pilot scale with single-use components.

  • Developing A Continuous Large-Scale Perfusion Cell Culture Process

    Perfusion processes enable continuous operation over extended periods of time by constantly providing fresh nutrients for the cells and simultaneously removing spent media and waste products, as compared to batch and fed-batch processes. The key benefits of perfusion processes are compact process design, flexibility, increased productivity, increased yield, and consistent product quality. The purpose of the described study is to demonstrate a connected mAb perfusion cell culture process using Xcellerex XDR 50 integrated with the Xcellerex Automated Perfusion System (APS).

  • Robust Process Development For cGMP Manufacturing Of Cell Therapies

    By leveraging early decisions around process development, quality assurance, and quality control strategies, you can set yourself up for a successful cGMP manufacturing workflow. This article will tackle how to approach process development with a manufacturing workflow mindset that will transition smoothly to cGMP manufacturing.

  • Security Of Supply In Cell And Gene Therapy Manufacturing

    With so many challenges in cell and gene therapy manufacturing, building an adequate supply chain with the necessary equipment and protocols is critical for companies pursuing these life-saving drugs.


Scaling down size, scaling up capabilities

Cost and speed are critical components in biomanufacturing. A compact chromatography system easily adjusted to fit projects needs can help you stay on top of this—whether you are developing a process or manufacturing at pilot scale.

The complexity of high cost biologics means comparator may be one of the highest line items in your clinical trial budget. Our Comparator Center of Excellence Team can consult and assist you in managing the full breadth of your comparator sourcing needs. Utilizing Fisher Clinical Services’ comparator sourcing services will provide you access to a global sourcing network and an overall de-risked supply chain. Currently 15 out of the top 20 worldwide pharmaceutical and biotechnology companies, as well many small pharmaceutical and biotech start-ups, actively utilize our comparator sourcing and strategy services.

Gibco BioProduction Services can support and partner with you no matter what your comfort level is with intellectual property.  Our team of professionals will work with you to provide the best customized solution for your particular situation.  You will receive exceptional customer service from start to finish.

The Falcon Tube Rack Storage System allows users to access an individual 1.4 ml polypropylene tube so an entire rack need not be thawed to retrieve one sample...
An integral part of the UHTSS is the Nanoplate, which is a screening platform that has 3,456 miniaturized wells in

The ZE5 Cell Analyzer is an innovative new flow cytometer with flexible configurations to meet a broad range of experimental complexities and throughput needs. Whether it’s a low-complexity, or a high-complexity experiment, the ZE5 Analyzer has up to 30 parameters and provides a truly expandable flow cytometer. This flexibility makes the ZE5 Analyzer accessible for novice flow cytometry users yet flexible enough for the most experienced flow cytometry professionals